42 studies found for:    Open Studies | "Bronchiectasis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Bronchiectasis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Natural History of Bronchiectasis
Conditions: Bronchiectasis;   Cystic Fibrosis;   Autoimmune Disease;   Common Variable Immunodeficiency
Intervention:
2 Recruiting Cross-sectional Characterization of Idiopathic Bronchiectasis
Conditions: Idiopathic Bronchiectasis;   Nontuberculous Mycobacterium (NTM) Infection
Intervention:
3 Unknown  Metabolomic Analysis of Exhaled Breath Condensates in Patients With COPD and Bronchiectasis
Conditions: COPD;   Bronchiectasis
Intervention:
4 Recruiting The Effect of Theophylline in the Treatment of Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Theophylline;   Drug: Placebo(for Theophylline)
5 Recruiting The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Formoterol-budesonide;   Drug: Theophylline;   Drug: Placebo
6 Unknown  Exercise Capacity in Bronchiectasis Resection
Condition: Bronchiectasis
Intervention:
7 Recruiting The Prevalence and Impact of Depression and Anxiety Symptoms in Patients With Non-CF Bronchiectasis
Condition: Bronchiectasis
Intervention:
8 Recruiting Bacteriology and Inflammation in Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Fluroquinolones;   Drug: Beta-lactamase inhibitor
9 Recruiting Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis
Condition: Bronchiectasis
Intervention: Drug: Tobramycin
10 Recruiting A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Tobramycin;   Drug: Saline
11 Recruiting Tayside Rehabilitation in Bronchiectasis Exacerbations (TRIBE) : a Randomized Controlled Trial
Condition: Bronchiectasis
Intervention: Procedure: Pulmonary rehabilitation
12 Recruiting ELTGOL and Bronchiectasis. Respiratory Therapy
Conditions: Respiratory; Complications, Therapy;   Bronchiectasis
Interventions: Procedure: Low Expiration Open glottis inferolateral (ELTGOL);   Procedure: Stretching
13 Unknown  A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
Conditions: Asthma;   Bronchiectasis
Interventions: Drug: DAS181 dry powder, formulation F02;   Drug: Respitose ML006 (DMV-Fonterra)
14 Unknown  Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in Bronchiectasis
Condition: Bronchiectasis
Interventions: Other: Hypertonic saline;   Other: Isotonic saline
15 Recruiting Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations
Condition: Bronchiectasis
Interventions: Other: Duration;   Drug: Colomycin;   Drug: Meropenem
16 Recruiting Pulmonary Rehabilitation Program (PRP) Versus PRP Plus Nutritional Supplementation in Patients With Bronchiectasis
Condition: Bronchiectasis
Interventions: Other: Pulmonary Rehabilitation;   Dietary Supplement: Hyperproteic oral nutritional supplement enriched with beta-hydroxy-beta-methylbutyrate
17 Recruiting The Role of Viral Infection in Acute Exacerbations of Non-cystic Fibrosis Bronchiectasis in Adults
Condition: Bronchiectasis
Intervention:
18 Recruiting Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Condition: Bronchiectasis
Interventions: Drug: Ciprofloxacin DPI (BAYQ3939);   Drug: Placebo
19 Recruiting Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Condition: Bronchiectasis
Interventions: Drug: Ciprofloxacin: administered for 28 days on / 28 days off;   Drug: Placebo: administered for 28 days on / 28 days off;   Drug: Ciprofloxacin: administered for 14 days on / 14 days off;   Drug: Placebo: administered for 14 days on / 14 days off
20 Recruiting Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.
Conditions: Bronchiectasis;   Lower Respiratory Infection
Intervention: Drug: POL7080

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years